DAKTARIN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug DAKTARIN contains one active pharmaceutical ingredient (API):

1 Miconazole
UNII VW4H1CYW1K - MICONAZOLE NITRATE

Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis.

Read about Miconazole

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DAKTARIN Oral gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DAKTARIN Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GYNO-DAKTARIN Vaginal cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A01AB09 Miconazole A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AB Antiinfectives and antiseptics for local oral treatment
Discover more medicines within A01AB09
D01AC02 Miconazole D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC02
G01AF04 Miconazole G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 9027D, 9028E, 9029F, 9031H
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 514500403165314
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01058906, 04289144
Country: EE Ravimiamet Identifier(s): 1024579, 1828379
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 50271, 55962
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 482913, 528837
Country: FR Base de données publique des médicaments Identifier(s): 62555293, 69184289
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 138617, 147179, 147183, 31644, 34584, 34588, 34589, 37792, 37795
Country: IE Health Products Regulatory Authority Identifier(s): 59803, 59811, 77623
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 1359, 5301
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1012382, 1053042, 1061420, 1076720, 1078433, 1084598, 1084980, 1085244, 1085614, 1085846, 1090619
Country: MT Medicines Authority Identifier(s): MA1471/00101, MA1471/00102, MA1471/00103, PI908/05201B, PI908/05202A
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 396M79, 76970
Country: NL Z-Index G-Standaard Identifier(s): 12112097, 12112143, 12112178, 13608762
Country: NL Z-Index G-Standaard, PRK Identifier(s): 2461, 4650, 4669, 72400
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 2054, 2057, 2059, 2061, 2062
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100016877, 100075928, 100082213, 100122102, 100193869, 100194857, 100259479, 100260264, 100263386, 100298025, 100324567, 100324610, 100350033, 100384345, 100396851, 100401380, 100407075, 100427557, 100463627
Country: SG Health Sciences Authority Identifier(s): 01114P, 01115P, 02028P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 8833031
Country: ZA Health Products Regulatory Authority Identifier(s): L/20.2.2/183

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.